F. Ahammad, M. Howlader, R. Barnab, M. Ali, S. Naher, and M. Islam, “Incretin-Based Antidiabetic Agents: A New Option for Type-2 Diabetes Mellitus”, Faridpur Med Coll J, vol. 6, no. 1, pp. 51–54, Apr. 2011.